This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Safeway and Compliments Ibuprofen Liquid Capsules: Labeling Error
- Starting date:
- August 2, 2013
- Posting date:
- August 2, 2013
- Type of communication:
- Advisory
- Subcategory:
- Drugs
- Source of recall:
- Health Canada
- Issue:
- Labelling and Packaging
- Audience:
- General Public
- Identification number:
- RA-34867
- Issue
- What you should do
- Who is affected
- Report health or safety concerns
- Related AWRs
- What Health Canada is doing
- Images
Issue
Health Canada is advising Canadians that Vita Health Products Inc. is voluntarily recalling all lots of Safeway Ibuprofen Liquid Capsules (200 mg capsules, 72 in a bottle) and Compliments Ibuprofen Liquid Capsules (200 mg, 72 capsules in a bottle). The recall is due to a labeling error that incorrectly states the products are packaged with a child-resistant cap.
Health Canada is aware that Vita Health Products Inc. has requested that retailers return the impacted lots to the company.
| Lot number | Manufacture Date | Expiry Date |
|---|---|---|
| 1J1612FLH | OC2011 | 10/31/2013 |
| 2G0622S9L | MA2012 | 05/31/2014 |
| 2J2582VLV | AU2012 | 08/31/2014 |
| 2J2592VLV | AU2012 | 08/31/2014 |
| 2K0562VLV | AU2012 | 08/31/2014 |
| 2K0582VLV | SE2012 | 09/30/2014 |
| 2L3262Y40 | OC2012 | 10/31/2014 |
| 3C18630HR | DE2012 | 12/31/2014 |
| 3C25730HR | DE2012 | 12/31/2014 |
| 3C36532HA | JA2013 | 01/31/2015 |
| Lot Number | Manufacture Date | Expiry Date |
|---|---|---|
| 1I1102GSC | AU2011 | 08/31/2013 |
| 1I1112GSC | AU2011 | 08/31/2013 |
| 1J0082FLM | SE2011 | 09/30/2013 |
| 1J0322FLM | SE2011 | 09/30/2013 |
| 2A1582NK9 | SE2011 | 12/31/2013 |
| 2E1842QJ5 | JA2012 | 01/31/2014 |
| 2F1172RFS | AL2012 | 04/30/2014 |
| 2F1382RFS | AL2012 | 04/30/2014 |
| 2L2782X86 | SE2012 | 09/30/2014 |
What you should do
- Keep all medication out of reach of children.
- Check to see if they have any of the affected lots in their possession.
- Return the impacted lots to the place of purchase.
- Consumers who have any questions about these products can call the company.
- Report any adverse reactions to Health Canada.
Who is affected
These products pose a risk to children who could open the bottle and ingest the bottle’s contents. The risk of ingestion by children can result in ibuprofen overdose and serious health consequences including, seizures, kidney failure, heart problems and coma. Early signs of overdose include nausea, vomiting, lethargy and abdominal pain.
Report health or safety concerns
- Call toll-free at 1-866-234-2345
- Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Related AWRs
Safeway Extra Strength Ibuprofen: Labelling Error Could Lead to Serious Harm to Children
2013-06-06 | Health products
What Health Canada is doing
Health Canada is monitoring Vita Health’s recall and will inform Canadians if new information comes to light. Vita Health Products Inc. has informed Health Canada that as of July 30, 2013, there had been no adverse reactions reported concerning these products. As well, Health Canada had not received any adverse reaction reports related to this issue as of July 19, 2013.
Images
Select thumbnail to enlarge - opens in a new window
